Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan

Journal of the National Cancer Institute

Volumn 94, Issue 23, 2002, Pages 1780-1789

  Hildesheim, Allan ^a   Apple, Raymond J ^g   Chen, Chien Jen ^b   Wang, Sophia S ^a   Cheng, Yu Juen ^b   Klitz, William ^c   Mack, Steven J ^c   Chen, I How ^d   Hsu, Mow Ming ^e   Yang, Czau Siung ^b   Brinton, Louise A ^a   Levine, Paul H ^f   Erlich, Henry A ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d MACKAY MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g George Washington University ^*

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CARCINOGENESIS; CAUCASIAN; CHINESE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; ETHNIC GROUP; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; GROUPS BY SEX; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RACE DIFFERENCE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TAIWAN;

EID: 0037021662     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.23.1780     Document Type: Article

References (58)

1. Yu MC, Henderson BE. Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York (NY): Oxford University Press; 1996. p. 603-18.
2. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 1993;15:466-85.
3. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, et al. Serologic markers of EBV infection and NPC in Taiwanese men. New Engl J Med 2001;345:1877-82.
4. Ward MH, Pan WH, Cheng YJ, Lin FH, Brinton LA, Chen CJ, et al. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer 2000;86:603-9.
5. Colburn NH, Ozanne S, Lichti U, Ben T, Yuspa SH, Wendel E, et al. Retinoids inhibit promoter-dependent preneoplastic progression in mouse epidermal cell lines. Ann N Y Acad Sci 1981 Feb 27;359:251-9.
6. Yu MC. Nasopharyngeal carcinoma: epidemiology and dietary factors. IARC Sci Publ 1991;(105):39-47.
7. Nam JM, McLaughlin JK, Blot WJ. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U.S. whites. J Natl Cancer Inst 1992;84:619-22.
8. Cheng YJ, Hildesheim A, Hsu MM, Chen IH, Brinton LA, Levine PH, et al. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control 1999;10:201-7.
9. Vaughan TL, Stewart PA, Teschke K, Lynch CF, Swanson GM, Lyon JL, et al. Occupational exposure to formaldehyde and wood dust and nasopharyngeal carcinoma. Occup Environ Med 2000;57:376-84.
10. West S, Hildesheim A, Dosemeci M. Non-viral risk factor for nasopharyngeal carcinoma in The Philippines: results from a case-control study. Int J Cancer 1993;55:1-6.
11. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990;346:470-1.
12. Chan SH, Chew CT, Prasad U, Wee GB, Srinivasan N, Kunaratnam N. HLA and nasopharyngeal carcinoma in Malays. Br J Cancer 1985;51: 389-92.
13. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997;89:1207-12.
14. Nazar-Stewart V, Vaughan TL, Burt RD, Chen C, Berwick M, Swanson GM. Glutathione S-transferase m1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 1999;8:547-51.
15. th ed. Stamford (CT): Appleton & Lange; 1996.
16. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6:157-62.
17. Hildesheim A, Schiffman M, Scott DR, Marti M, Kissner T, Sherman ME, et al. HLA class I/II alleles and development of HPV-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol Biomarkers Prev 1998;7:1035-41.
18. Krul EJ, Schipper RF, Schreuder GM, Fleuren GJ, Kenter GG, Melief CJ. HLA and susceptibility to cervical neoplasia. Hum Immunol 1999;60: 337-42.
19. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991;352:723-5.
20. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research. Lancet 1999;354:2119-24.
21. Donaldson PT, Ho S, Williams R, Johnson PJ. HLA class II alleles in Chinese patients with hepatocellular carcinoma. Liver 2001;21:143-8.
22. Fanning LJ, Levis J, Kenny-Walsh E, Whelton M, O'Sullivan K, Shanahan F. HLA class II genes determine the natural variance of hepatitis C viral load. Hepatology 2001;33:224-30.
23. Wang SS, Hildesheim AG, Schiffman M, Herrero R, Bratti MC, Sherman ME, et al. Comprehensive analysis of human leukocyte antigen (HLA) class I alleles and cervical neoplasia in three epidemiological studies. J Infect Dis 2002;186:598-605.
24. Simons MJ, Wee GB, Goh EH, Chan SH, Shanmugaratnam K, Day NE, et al. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2). J Natl Cancer Inst 1976;57:977-80.
25. Chan SH, Day NE, Kunaratnam N, Chia KB, Simons MJ. HLA and nasopharyngeal carcinoma in Chinese-a further study. Int J Cancer 1983;32: 171-6.
26. Burt RD, Vaughan TL, Nisperos B, Swanson M, Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int J Cancer 1994;56:465-7.
27. Dardari R, Khyatti M, Jouhadi H, Benider A, Ettayebi H, Kahlain A, et al. Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma. Int J Cancer 2001;92:294-7.
28. Simons MJ, Wee GB, Chan SH, Shanmugaratnam K. Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet 1975;1:142-3.
29. Wu SB, Hwang SJ, Chang AS, Hsieh T, Hsu MM, Hsieh RP, et al. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res 1989;9:1649-53.
30. Moore SB, Pearson GR, Neel HB, Weiland LH. HLA and nasopharyngeal carcinoma in North American caucasoids. Tissue Antigens 1983;22:72-5.
31. Herait P, Tursz T, Guillard MY, Hanna K, Lipinski M, Micheau C, et al. HLA-A, -B, and DR antigens in North African patients with nasopharyngeal carcinoma. Tissue Antigens 1983;22:335-41.
32. Li PK, Poon AS, Tsao SY, Ho S, Tam JS, So AK, et al. No association between HLA-DQ and DR genotypes with nasopharyngeal carcinoma in southern Chinese. Cancer Genet Cytogenet 1995;81:42-5.
33. Hildesheim A, Dosemeci M, Chan CC, Chen CJ, Cheng YJ, Hsu MM, et al. Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2001;10: 1145-53.
34. Scharf SJ, Griffith RL, Erlich HA. Rapid typing of DNA sequence polymorphism at the HLA-DRB1 locus using the polymerase chain reaction and nonradioactive oligonucleotide probes. Hum Immunol 1991;30:190-201.
35. Bugawan TL, Erlich HA. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenetics 1991;33:163-70.
36. Bugawan TL, Begovich AB, Erlich HA. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes. Immunogenetics 1991;34:413.
37. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992;148:249-58.
38. Apple RJ, Erlich HA. Two new HLA DRB1 alleles found in African Americans: implications for balancing selection at positions 57 and 86. Tissue Antigens 1992;40:69-74.
39. Shaw CK, Chen LL, Lee A, Lee TD. Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens 1999;53:51-64.
40. Huang HS, Peng JT, She JY, Zhang LP, Chao CC, Liu KH, et al. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum Immunol 1995;44:210-9.
41. Shaw CK, Chang TK, Chen SN, Wu S. HLA polymorphism and probability of finding HLA-matched unrelated marrow donors for Chinese in Taiwan. Tissue Antigens 1997;50:610-9.
42. Dixon WJ, Massey FJ. Introduction to statistical analysis. 4th ed. New York (NY): McGraw-Hill; 1983.
43. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York (NY): John Wiley & Sons; 1981.
44. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980;(32):5-338.
45. Lewontin RC. The interaction of selection and linkage. I. General considerations: heterotic models. Genetics 1964;49:49-67.
46. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing for multiple locus-locus haplotypes. Am J Hum Genet 1995;56:799-810.
47. Baur MP, Danilovs J. Population genetic analysis of HLA-A, B, C, DR and other genetic markers. In: Terisaki PI, editor. Histocompatibility testing. Los Angeles (CA): UCLA Tissue Typing Laboratory; 1980. p. 955-93.
48. Ren EC, Law GC, Chan SH. HLA-A2 allelic microvariants in nasopharyngeal carcinoma. Int J Cancer 1995;63:213-5.
49. Krausa P, Brywka M, Savage D, Hui KM, Bunce M, Ngai JL, et al. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 1995;45:223-31.
50. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 1997;15:405-31.
51. Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB. Conserved CTL epitopes within EBV latent membrane protein 2. J Immunol 1997; 158:3325-34.
52. Khanna R, Burrows SR, Nicholls J, Poulsen LM. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur J Immunol 1998;28:451-8.
53. Bryden H, MacKenzie J, Andrew L, Alexander FE, Angus B, Krajewski AS, et al. Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein. Int J Cancer 1997;72:614-8.
54. Lin M, Chu CC, Chang SL, Lee HL, Loo JH, Akaza T, et al. The origin of Minnan and Hakka, the so-called "Taiwanese", inferred by HLA study. Tissue Antigens 2001;57:192-9.
55. Bugawan TL, Klitz W, Blair A, Erlich HA. High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci. Tissue Antigens 2000;56:392-404.
56. De Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993;260:98-100.
57. Burrows JM, Burrows SR, Poulsen LM, Sculley TB, Moss DJ, Khanna R. Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J Virol 1996;70:2490-6.
58. Gavioli R, Kurilla MG, De Campos-Lima PO, Wallace LE, Dolcetti R, Murray AB, et al. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 1993;67:1572-8.